A cewar FMI - wani kamfanin bincike na kasuwa na ESMAR, an kiyasta kasuwar oligonucleotide API na duniya zai kai dala biliyan 3 a cikin 2020, kuma ya shaida CAGR na 11% ta 2030.
Don Samun Samfurin Kwafin Rahoton ziyarci @ https://www.futuremarketinsights.com/reports/sample/rep-gb-11933
Dangane da binciken FMI, ya zuwa yanzu, 100+ oligonucleotide APIs suna cikin matakan gwaji na asibiti, kuma amincewar tsari yana kan katunan. Bayan amincewa, buƙatar ƙarfin samarwa za ta ba da shaida, ta yadda za a fitar da kasuwar oligonucleotide API zuwa 2030.
Ana kallon Oligonucleotides azaman babban rukuni na warkewa na gaba wanda ke bin ilimin halittu da kwayoyin halitta. Ana iya danganta wannan ga tabbacin da suka bayar na samar da magunguna a farashi mai rahusa.
Baya ga maganin rigakafi, ƙwayoyin cuta da cututtukan zuciya da jijiyoyin jini, da ciwon daji, oligonucleotide APIs ana gwada su don magance cututtukan jijiya kamar Alzheimer kuma. Koyaya, abubuwa kamar rikitattun tsari da isar da oligonucleotides akan lokaci (a tsakanin Covid-19) suna aiki azaman kamewa.
Maɓalli Maɓalli daga Nazarin Alamar API na Oligonucleotide
- Ana sa ran APIs na Antisense Oligonucleotides zai kai dalar Amurka biliyan 4 nan da 2030.
- Arewacin Amurka da Turai gabaɗaya sun sami sama da kashi 47% na rabon kudaden shiga a cikin 2019 yayin da ake sa ran Asiya Pasifik za ta yi girma cikin sauri mafi sauri a lokacin hasashen.
- Haɓaka amfani da maganin antisense oligonucleotide APIs (musamman bayan amincewa daga FDA ta Amurka a cikin 2016) don haɓaka kasuwa a cikin lokacin hasashen.
Sabuwar Samfurin Ƙaddamarwa: Maɓallin Maɓalli zuwa Kasuwar APIs Oligonucleotide
FMI ta bincikar 'yan wasa kamar Akcea Therapeutics, Biogen, Sarepta Therapeutics, Jazz Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., da Dynavax Technologies a cikin wannan rahoton. Bisa ga bincike, waɗannan 'yan wasan suna ƙarfafa matsayinsu ta hanyar sababbin samfurori.
Misali -
- A cikin Maris 2020, Dynavax ya shiga haɗin gwiwa tare da Clover Biopharmaceuticals don haɓaka ɗan takarar rigakafi don yaƙar Covid-19. Clover yana cikin ingantacciyar kimantawa na Covid-19 S-Trimer, ɗan takarar rigakafin cutar sankara na furotin kuma Dynavax yana da ƙwarewar fasaha tare da mai karɓar mai karɓa na 9 (TLR9) agonist adjuvant, CpG 1018 don aiwatar da wannan.
- Alnylam Pharmaceuticals, Inc., a cikin 2018, ya ƙaddamar da Givlaari da Onpattro a matakin kasuwanci.
“Yanayin haɓakar inorganic haɗe tare da fa'idodin warkewa a ciki Gene far ana sa ran zai karfafa kasuwar oligonucleotide API” in ji manazarcin FMI.
Tambayi Manazarta @ https://www.futuremarketinsights.com/ask-question/rep-gb-11933
Gene Therapy da Oligonucleotide APIs
Ana amfani da oligonucleotides na roba a cikin maganin kwayoyin halitta don hana kwayoyin halittar da ke taimakawa wajen yada cutar. Ana amfani da APIs na Antisense oligonucleotide don tarwatsa kuskuren rubutun kwayoyin halitta.
Hakanan, ana iya amfani da siRNA don sigina tantanin halitta don tarwatsa fassarar mRNA mara kyau. Tare da waɗannan layin, Pharmamar, a cikin Janairu 2020, ya rattaba hannu kan yarjejeniya tare da Jazz Pharmaceuticals don siyar da API don "lurbinectedin", ɗayan jiyya na ƙarshen zamani don SCLC (kananan ciwon huhu) ta yadda ƙarshen zai iya yin kasuwanci.
Kuna son ƙarin fahimta?
Binciken yana ba da haske mai gamsarwa akan kasuwar Oligonucleotide API akan nau'in API daki-daki ya rufe kowane bangare na kasuwa kamar Antisense Oligonucleotides API, Short Interfering RNA (siRNA) API, Phosphorodiamidate Morpholino Oligonucleotides (PMO) API, MiRNA API, Aptamers API, CpG Oligonucleotides API da Sauransu (ON Conjugates (NP), ShRNA, da dai sauransu), Matsayin Kasuwanci (Kasuwanci, Gwaje-gwaje na Clinical (Matsalolin Kula da Lafiya)), da masu amfani da ƙarshen (Kamfanonin Magunguna da Kamfanonin Kimiyyar Halittu)) a cikin manyan yankuna bakwai.
Nemo Cikakken Rahoton a: https://www.futuremarketinsights.com/reports/oligonucleotide-api-market